comparemela.com

Latest Breaking News On - Onconova therapeutics inc - Page 2 : comparemela.com

HanxBio announces the publication of a research paper in Scientific Reports on preclinical evaluation of Narazaciclib for the treatment of acute myeloid leukemia (AML)

HanxBio announces the publication of a research paper in Scientific Reports on preclinical evaluation of Narazaciclib for the treatment of acute myeloid leukemia (AML)
streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.

Wuhan
Hubei
China
United-states
Bruce-zhong
Henry-li
Hanxbio-inc
Onconova-therapeutics-inc
Kyinno-biotech-ltd
Traws-pharma-inc
Crown-bioscience-inc
Nature-portfolio

HanxBio announces the publication of a research paper in Scientific Reports on preclinical evaluation of Narazaciclib for the treatment of acute myeloid leukemia (AML) | Taiwan News

HanxBio announces the publication of a research paper in Scientific Reports on preclinical evaluation of Narazaciclib for the treatment of acute myeloid leukemia (AML) | Taiwan News
taiwannews.com.tw - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from taiwannews.com.tw Daily Mail and Mail on Sunday newspapers.

China
Wuhan
Hubei
United-states
Henry-li
Kyinno-biotech-ltd
Traws-pharma-inc
Hanxbio-inc
Crown-bioscience-inc
Onconova-therapeutics-inc
Nature-portfolio
Onconova-therapeutics

Onconova Therapeutics (NASDAQ:ONTX) Earns Sell Rating from Analysts at StockNews.com

StockNews.com started coverage on shares of Onconova Therapeutics (NASDAQ:ONTX – Free Report) in a research note released on Tuesday morning. The firm issued a sell rating on the biopharmaceutical company’s stock. Onconova Therapeutics Price Performance The firm has a 50 day simple moving average of $0.82 and a 200 day simple moving average of $0.74. […]

United-states
Millennium-management
Renaissance-technologies
Onconova-therapeutics-inc
Beacon-pointe-advisors
Vanguard-group-inc
Onconova-therapeutics
Free-report
Pointe-advisors
Vanguard-group
Get-free-report

StockNews.com Begins Coverage on Onconova Therapeutics (NASDAQ:ONTX)

StockNews.com Begins Coverage on Onconova Therapeutics (NASDAQ:ONTX)
theenterpriseleader.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from theenterpriseleader.com Daily Mail and Mail on Sunday newspapers.

United-states
Vanguard-group-inc
Millennium-management
Onconova-therapeutics-inc
Renaissance-technologies
Beacon-pointe-advisors
Onconova-therapeutics
Get-free-report
Pointe-advisors
Vanguard-group
Onconova-therapeutics-daily

Onconova Therapeutics (NASDAQ:ONTX) Receives New Coverage from Analysts at StockNews.com

Stock analysts at StockNews.com started coverage on shares of Onconova Therapeutics (NASDAQ:ONTX – Get Free Report) in a note issued to investors on Monday. The brokerage set a “sell” rating on the biopharmaceutical company’s stock. Onconova Therapeutics Price Performance The stock has a market cap of $20.90 million, a PE ratio of -1.09 and a […]

United-states
Millennium-management
Onconova-therapeutics-company-profile
Beacon-pointe-advisors
Onconova-therapeutics-inc
Renaissance-technologies
Vanguard-group-inc
Onconova-therapeutics
Get-free-report
Pointe-advisors
Vanguard-group

© 2024 Vimarsana

vimarsana © 2020. All Rights Reserved.